Perampanel May Help Control Seizures in Alzheimer’s Patients
Researchers studied the connection between Alzheimer’s disease (AD) and epilepsy, focusing on how these two conditions can affect each other.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
Researchers studied the connection between Alzheimer’s disease (AD) and epilepsy, focusing on how these two conditions can affect each other.
Researchers studied a technique called transcranial focused ultrasound (tFUS), which is a non-invasive way to stimulate specific areas of the brain using sound waves.
Researchers studied neuron-specific enolase (NSE), an enzyme found in nerve cells, to see how it could help diagnose various neurological and psychiatric disorders.
A study was conducted in China, Japan, and South Korea to evaluate the effectiveness and safety of a medication called cenobamate for adults aged 18 to 70 who have uncontrolled focal seizures.
This study looked at epilepsy in people with a rare genetic condition called dentatorubral-pallidoluysian atrophy (DRPLA).
Researchers studied a rare condition called Pyridoxine-Dependent Epilepsy (PDE), which is caused by changes in a gene known as ALDH7A1.
This study looked at children with epilepsy and movement disorders, known as EPIMDs, to better understand their genetic causes and how these conditions present.
Researchers studied a gene called BAIAP2 to understand its role in developmental and epileptic encephalopathies (DEEs), which are severe forms of epilepsy that can affect a child’s development.
Researchers studied the use of cannabidiol, a compound found in cannabis, in children with developmental and epileptic encephalopathies (DEEs).